These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 757060)

  • 1. Further observations on the effect of azathioprine on chronic nonremitting multiple sclerosis.
    Rosen JA
    Trans Am Neurol Assoc; 1978; 103():209-12. PubMed ID: 757060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U; Haller P; Haas J; Pocklington P; Deicher H
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide and imuran. Report on 57 cases].
    Göpel W; Benkenstein H; Banzhaf M
    Dtsch Gesundheitsw; 1972 Oct; 27(41):1955-61. PubMed ID: 4637249
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V; Spadaro M; Tilia G
    Riv Neurol; 1987; 57(3):185-8. PubMed ID: 3313667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 7. A preliminary evaluation of azathioprine (Imuran) in the treatment of multiple sclerosis.
    Tucker WG; Kapphahn KH
    Henry Ford Hosp Med J; 1969; 17(2):89-92. PubMed ID: 5783817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary results of imurek treatment of multiple sclerosis].
    Müller J; Kreiner R; Sauermann W
    Psychiatr Neurol Med Psychol (Leipz); 1976 Dec; 28(12):755-61. PubMed ID: 1019278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern views on the treatment of multiple sclerosis].
    Sieniarski A
    Wiad Lek; 1974 Feb; 27(4):337-40. PubMed ID: 4360561
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 15. [New proposals for the treatment of multiple sclerosis. Preliminary study].
    Floris V; Spadaro M
    Riv Neurol; 1985; 55(3):169-84. PubMed ID: 4035256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary results of azathioprine treatment in disseminated sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1971; 5(6):829-35. PubMed ID: 5139005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
    Ventre JJ; Guillot M; Confavreux C; Evreux JC; Aimard G
    Therapie; 1985; 40(3):195-202. PubMed ID: 4012666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 19. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.